Together, by fully funding R&D for testing, treatment and vaccines, we can achieve COVID-Zero: no more preventable deaths, no more lockdowns and no more disruption.
All R&D funders, developers and manufacturers must help ensure that new vaccines, diagnostics and treatments developed for COVID-19 are globally available, appropriate and affordable, regardless of where they have been developed or who has funded them.
We want to help the world overcome Covid-19. Research is the best way to save lives – but more investment in accessible treatments, tests and vaccines is urgently needed to change the course of the pandemic.
At least $8 billion of new funding is needed for the global response to COVID-19 – for research, development and supply of treatments for all, and support for public health measures in countries with the weakest health systems.
Every two to three years we survey over 2000 adults to understand public knowledge about and interest in science and health research.
Research on research (also known as meta-research, the science of science and meta-science) is the study of research itself.
Current practices prioritise outputs over people’s wellbeing. We want to help build a better research culture – one that is creative, inclusive and honest.
Artificial intelligence (AI) and data technologies are transforming research and healthcare. We want to make sure everyone benefits from health data innovation.
Following the work led by Jim Smith in reviewing the way we support science, Wellcome is now reviewing its wider strategy.
How Wellcome is working to ensure that research evidence is used to influence policy and practice.
This is one of the world’s biggest hidden health crises. We want to transform the way snakebite treatments are researched and delivered to bring them into the 21st century.
Research is an essential part of being ready for and responding to public health emergencies, like COVID-19 and Ebola.
Wellcome is working with the World Health Organization (WHO) to take on big challenges in global health.
Randomised clinical trials are essential to advancing evidence-based medicine and improving human health. But new guidelines are needed, which is why we've launched the Good Clinical Trials Collaborative.
Wellcome Leap is a not-for-profit organisation set up by Wellcome to accelerate discovery and innovation for the benefit of human health.
The world is decades behind on mental health. We are leading a radical new approach to drive the science forward and improve people’s lives.
Read summaries of the grants awarded under the Our Planet, Our Health programme.
Everyone should have access to the life-changing benefits of medicines and other healthcare interventions, like vaccines, diagnostics and therapies.
The Surveillance and Epidemiology of Drug-resistant Infections Consortium (SEDRIC) brings together a range of international experts to share expertise and take action to tackle the gaps in drug-resistant infections surveillance and epidemiology.
We want the research we fund – like publications, data, software and materials – to be open and accessible, so it can have the greatest possible impact.